The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(6-(6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazin-1-yl)-N-(3-(2-chloroacetamido)propyl)propanamide ID: ALA4872839
PubChem CID: 164624357
Max Phase: Preclinical
Molecular Formula: C32H42ClN9O4
Molecular Weight: 652.20
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(CCC(=O)NCCCNC(=O)CCl)CC4)cn3)nc2n(C2CCCC2)c1=O
Standard InChI: InChI=1S/C32H42ClN9O4/c1-21-25-20-37-32(39-30(25)42(23-6-3-4-7-23)31(46)29(21)22(2)43)38-26-9-8-24(19-36-26)41-16-14-40(15-17-41)13-10-27(44)34-11-5-12-35-28(45)18-33/h8-9,19-20,23H,3-7,10-18H2,1-2H3,(H,34,44)(H,35,45)(H,36,37,38,39)
Standard InChI Key: JJJZGTMZVYXLJB-UHFFFAOYSA-N
Molfile:
RDKit 2D
46 50 0 0 0 0 0 0 0 0999 V2000
29.5881 -19.4599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5881 -20.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2934 -20.6815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.2934 -19.0472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9987 -19.4599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9971 -20.2753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7013 -20.6826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4076 -20.2756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4052 -19.4571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7004 -19.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8810 -20.6867 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.2934 -18.2300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8792 -19.0534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8768 -18.2362 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.1727 -19.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2979 -21.5019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6375 -21.9832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8912 -22.7600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7084 -22.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9597 -21.9813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1157 -20.6835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8230 -20.2742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5294 -20.6847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2362 -20.2761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2359 -19.4580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5228 -19.0503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8189 -19.4612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.9426 -19.0477 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.6513 -19.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9407 -18.2306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6475 -17.8203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3561 -18.2272 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0629 -17.8170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3580 -19.0444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.7715 -18.2239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.4783 -17.8137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1869 -18.2206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.4764 -16.9965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.8937 -17.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6024 -18.2173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3091 -17.8071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0178 -18.2140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.7245 -17.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4332 -18.2107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.1399 -17.8005 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
43.7226 -16.9866 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 1 0
3 6 1 0
5 4 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 11 2 0
4 12 1 0
1 13 1 0
13 14 2 0
13 15 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 16 1 0
3 16 1 0
8 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
25 28 1 0
28 29 1 0
28 30 1 0
30 31 1 0
29 34 1 0
31 32 1 0
32 33 1 0
32 34 1 0
33 35 1 0
35 36 1 0
36 37 1 0
36 38 2 0
37 39 1 0
39 40 1 0
40 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
44 45 1 0
43 46 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 652.20Molecular Weight (Monoisotopic): 651.3048AlogP: 2.93#Rotatable Bonds: 13Polar Surface Area: 154.45Molecular Species: NEUTRALHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.34CX Basic pKa: 7.87CX LogP: 1.90CX LogD: 1.31Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.14Np Likeness Score: -1.26
References 1. Shan H, Ma X, Yan G, Luo M, Zhong X, Lan S, Yang J, Liu Y, Pu C, Tong Y, Li R.. (2021) Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold., 219 [PMID:33857728 ] [10.1016/j.ejmech.2021.113432 ]